ArticleBlood advances2023

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.

Christopher J Forlenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.